SUPERLUMINAL PARTNERS
Superluminal Partners is a venture capital and private equity firm.
Similar Organizations
Aligned Deal Sourcing
Aligned Deal Sourcing is a Venture Capital and Private Equity firm.
Armada IP Capital
Armada IP Capital is a venture capital and private equity firm.
Propeller Investments
Propeller Investments is a venture capital and private equity firm.
Zephyr Management
Zephyr Management is a venture capital and private equity firm.
Current Employees Featured
More informations about "Superluminal Partners"
Home - Superluminal
Superluminal is eligible to receive up to $1.3 billion, which includes upfront and near-term payments, an equity investment, development and commercial milestones, as well as tiered …See details»
Superluminal Partners - Crunchbase Investor Profile
Superluminal Partners is a venture capital and private equity firm.See details»
Eli Lilly signs $1.3 billion deal with Superluminal to use AI to make ...
Aug 14, 2025 Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop small-molecule drugs through AI to treat obesity and other …See details»
Superluminal Medicines and Eli Lilly Form $1.3 Billion …
6 days ago Superluminal partners with Eli Lilly to develop AI-driven small molecule therapies targeting GPCRs for obesity and cardiometabolic diseases, aiming for innovative treatments.See details»
Superluminal Medicines - Funding & Investors - Tracxn
Jul 30, 2025 Superluminal Medicines has raised a total funding of $153M over 2 rounds from 7 investors. Investors include RA Capital Management, Insight Partners and 5 others. Their …See details»
Superluminal Medicines Launches with $33 Million Seed Round to …
Sep 6, 2023 BOSTON, Aug. 28, 2023 (GLOBE NEWSWIRE) — Superluminal Medicines Inc., a generative biology and chemistry company developing a differentiated pipeline and …See details»
Superluminal Medicines Announces Collaboration with Eli Lilly and ...
Superluminal is headquartered in Lilly Gateway Labs, Boston, and is backed by a strong network of investors, including RA Capital Management, Insight Partners, NVentures (NVIDIA’s …See details»
Adam Apollo | Masterminding EDEN
I’m Adam Apollo, co-founder and CEO of Superluminal Systems, and CoreNexus™ is our magnum opus, a platform designed to gamify planetary stewardship at scale. My journey has …See details»
Eli Lilly (LLY) Partners with Superluminal for AI Drug Discovery - MSN
The deal allows Eli Lilly and Company (NYSE:LLY) to have exclusive rights to develop and commercialize drug candidates discovered with the help of Superluminal’s proprietary AI …See details»
Eli Lilly Partners with Superluminal in $1.3 Billion Obesity Deal
Aug 14, 2025 Eli Lilly has entered into a significant collaboration with Superluminal, a machine learning-driven startup, aiming to advance research and development in obesity treatments. …See details»
Eli Lilly Keeps Obesity Pipeline Fresh With $1.3B Superluminal ...
Aug 14, 2025 The Boston-based AI/ML startup focuses on endocrine and cardiometabolic diseases and will use that expertise to generate new small molecule obesity medications for …See details»
Superluminal Medicines Announces Collaboration with Eli Lilly and ...
Aug 14, 2025 The collaboration will leverage Superluminal's cutting-edge, structure-based drug discovery platform, combined with Lilly's small molecule development and commercialization …See details»
Lilly signs up to $1.3 billion deal with Superluminal to develop
(Reuters) -Superluminal Medicines said on Thursday it had signed a deal with U.S. drugmaker Eli Lilly worth up to $1.3 billion to discover and develop obesity drugs. The deal will give Lilly ...See details»
Superluminal Partners - Profiles & Contacts - Crunchbase
Superluminal Partners is a venture capital and private equity firm.See details»
Eli Lilly partners with AI healthtech Superluminal Medicines
Superluminal Medicines, a healthcare company integrating AI/ML, announced partnership with Eli Lilly (NYSE:LLY) to advance small molecule therapeutics targeting cardiometabolic diseases …See details»
Eli Lilly Inks Up To $1.3B Deal With Superluminal Medicines To
Eli Lilly (LLY) has entered into a deal worth up to $1.3 billion with drug discovery company Superluminal Medicines to advance small molecule therapeutics relevant to cardiometabolic …See details»
Home - The StreetLight
Our mission is to build strong community by improving the quality of life for impoverished men, women and children, including the chronically homeless.See details»
AI: Lilly signs US$1.3 billion deal with Superluminal to discover ...
6 days ago Eli Lilly has signed a deal worth US$1.3 billion with privately held Superluminal Medicines to discover and develop small-molecule drugs through AI to treat obesity and other …See details»
Women In Community Action Inc. Inc.
Our mission is: Women In Community Action, Inc. is a membership organization dedicated to making a difference and enriching the lives of the citizens of the community through financial …See details»
Team - RQ Partners LLP.
In addition to his role at RQ Partners, LLP., John is an active member of the Canadian Bar Association of Ontario and the Canadian Italian Advocates Organization. He has also …See details»